期刊文献+

RYGBP与BPD对2型糖尿病大鼠的血糖控制及GLP-1表达的影响 被引量:4

Effect of RYGBP and BPD on Blood Glucose Control and GLP-1 Expression in Rats with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的评估Roux-en-Y胃旁路术(Roux-en-Y gastric bypass,RYGBP)与胆胰分流术(billiopancreatic diver-sion,BPD)对2型糖尿病(type 2diabetes mellitus,T2DM)大鼠的临床疗效。探讨胰升糖素样多肽1(glucagon-like pep-tide 1,GLP-1)在手术治疗T2DM中的机制。方法将36只雄性正常体质量Goto-Kakizaki(GK)大鼠随机分为RYG-BP,BPD与假手术组,每组12只。观测分析非肥胖T2DM大鼠术前及术后1周、2周、1个月、2个月、3个月的体质量、空腹血糖(fasting blood glucose,FBG)、血清胰岛素(insulin,INS)水平、糖化血红蛋白(glycosylated hemoglobin A1c,HbA1c)水平、GLP-1水平的变化。观察术后3个月T2DM大鼠的并发症及死亡率的发生情况,寻找最佳手术方式。结果与术前比较,术后1周~3个月RYGBP与BPD组GK大鼠FBG显著降低(P<0.05),空腹GLP-1明显升高(P<0.05),术后3个月HbA1c显著降低(P<0.05),术后3月空腹胰岛素水平显著升高(P<0.05)。假手术组上述指标均未见明显变化。BPD组GK大鼠死亡率与并发症发生率均较RYGBP组高。结论RYGBP较BPD对非肥胖T2DM具有更安全有效的治疗作用。RYGBP控制血糖可能与GLP-1升高促进胰岛素释放,改善β细胞功能有关。 Objective To observe the clinical efficacy of Roux-en Y gastric bypass (RYGBP) and billiopancreatic diversion (BPD) in the treatment of type 2 diabetes mellitus (T2DM) rats and investigate the change of glucagon-like pep- tide1 (GLP 1) expression in Goto-Kakizaki (GK) rats after surgery. Methods A total of 36 males GK rats were ran- domly divided into three groups: Roux-en-Y gastric bypass group (n = 12), billiopancreatic diversion group (n = 12), and sham operation group (n = 12). The body weight, fasting blood glucose (FBG), fasting insulin (INS), glycosylated he- moglobin (HbA1 c) levels and GLP I levels of the rats were determined before operation and 1 week, 2 weeks, 1 month, 2 months and 3 months after operation. The mortality and complication were observed. Results FBG levels were signifi- cantly decreased in 1 week - 3 months after operation in both RYGBP and BPD groups (P〈0. 05). GLP-1 expressions were significantly increased after operation (P〈0. 05). HbA1 c levels were decreased in 3 months after operation (P〈0. 05). The fasting INS levels were significantly increased in 3 months after operation (P〈0. 05). The above parameters didn't change in the sham operation group. The mortality and complication incidence in the BPD group were significantly higher than those in the RYGBP group. Conclusion RYGBP is more effective and safer in treating non-obese T2DM than BPD. The increase of GLP1 may help to advance β-cell function and increase insulin secretion.
出处 《华南国防医学杂志》 CAS 2013年第8期540-543,共4页 Military Medical Journal of South China
基金 湖北省自然科学基金项目(2010CDB09201)
关键词 2型糖尿病 ROUX-EN-Y胃旁路术 胆胰分流术 胰升糖素样多肽1 Goto-Kakizaki大鼠 Type 2 diabetes mellitus Roux en-Y gastric bypass Billiopancreatic diversion Glucagon-like peptide - 1 Goto-Kakizaki rats
  • 相关文献

参考文献13

  • 1Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J]. Diabetes Care,2004,27(5) : 1047-1053.
  • 2Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis[J]. JAMA, 2004, 292 (14) : 1724-1737.
  • 3White S, Brooks E, Jurikova L, et al. Long-term outcomes after gastric bypass[J]. Obes Surg,2005,15(2) : 155-163.
  • 4Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus[J]. Ann Intern Med,2004,141 (6):421-431.
  • 5Le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone pro- files following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters[J]. Ann Surg, 2006,243(1 ) : 108-114.
  • 6Rubino F, Gagner M, Gentileschi P,et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism [ J ]. Ann Surg, 2004, 240 (2) : 236-242.
  • 7Hoist JJ. The physiology of glucagon-like peptide 1 [J]. Physiol Rev, 2007,87 (4) : 1409-1439.
  • 8徐键,王勇,刘源,刘金钢.胃转流术治疗2型糖尿病的研究进展[J].中华内分泌外科杂志,2010,4(2):132-134. 被引量:8
  • 9Li Y, Hansotia T,Yusta B,et al. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis[J]. J Biol Chem 2003,278 (1):471-478.
  • 10田晓丰,曹宏,陈丹磊,柯重伟,印慨,郑成竹.胃旁路术对糖尿病大鼠胰岛β细胞凋亡的影响及其机制研究[J].中华外科杂志,2010,48(23):1794-1799. 被引量:6

二级参考文献46

  • 1张士虎,苗毅.胃旁路术对非肥胖型糖尿病大鼠的降糖作用[J].南京医科大学学报(自然科学版),2006,26(3):176-179. 被引量:13
  • 2Francesco R, Michel G. Potential of surgery for curing type 2 diabetes mellitus[ J]. Ann Surg, 2002,236(6) :554 - 559.
  • 3Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult -onset diabetes mellitus [ J ]. Ann Surg, 1995,222 ( 3 ) : 339 - 352.
  • 4Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mecganisms of weight loss and diabetes resolution[ J]. J Clin Endocri Metab,2004,89(6) :2608 -2615.
  • 5Wick remesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study [ J ]. Obes Surg,2005,15 ( 6 ) :474 - 481.
  • 6Wang Q, Brubaker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice [ J ]. Diabetologia, 2002,45(8) :1263 - 1273.
  • 7Simon A. Gastrointestinal surgery and gut hormones [ J ]. Current Opinon in Endocrinology & Diabetes,2005,12( 1 ) :89 -98.
  • 8Kral JG. Selection of patients for anti-obesity surgery [ J ]. Int J Obes,2001,25( Supp 1 ) :107 - 112.
  • 9Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus [ J ]. Ann surg,2003,238(4) :467 -484.
  • 10Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes;a new perspective for an old disease [ J ]. Ann Surg,2004,239 ( 1 ) : 1 - 11.

共引文献12

同被引文献36

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版).中国糖尿病杂志,2011,20(36):S2-S37.
  • 2Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27(5): 1047-1053.
  • 3Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab, 2000, 26(5): 363-369.
  • 4Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995, 222(3): 339-352.
  • 5Wang TT, Hu SY, Gao HD, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type IJ diabetes by increasing GLP-1. Ann Surg, 2008, 247(6): 968-975.
  • 6Depaula AL, Macedo AL, Mota BR, et al. Laparoscopic ileal interpo-sition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BM121-29. SurgEndosc, 2009, 23(6): 1313-1320.
  • 7American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care, 2010, 33 Suppl 1:$11-$61.
  • 8Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med, 2011, 28(6): 628-642.
  • 9Celik A, Ugale S, Ofluoglu H, et al. Metabolic outcomes of laparo- scopic diverted sleeve gastrectomy with ileal transposition (DSIT) in obese type 2 diabetic patients. Obes Surg, 2015, 25(11): 2018-2022.
  • 10Ersoz F, Duzkoylu Y, Deniz MM, et al. Laparoscopic Roux-en-Y gastric bypass with ileal transposition--an alternative surgical treatment for type 2 diabetes mellitus and gastroesophageal reflux. Wideochir Inne Tech Maloinwazyjne, 2015, 10(3): 481-485.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部